Login Register Cart 0
Generic placeholder image

Cardiovascular & Hematological Disorders-Drug Targets

Editor-in-Chief

ISSN (Print): 1871-529X
ISSN (Online): 2212-4063

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Clinical Dilemma, Bernard Soulier Syndrome versus Immune Thrombocytopenic Purpura: A Case Report

Author(s): Bhavya J, Nitish Kumar Patel, Nilesh Kumar, Jitendra Singh* and Kailash Kumar

Volume 23, Issue 1, 2023

Published on: 19 May, 2023

Page: [72 - 75] Pages: 4

DOI: 10.2174/1871529X23666230419095422

Price: $65

Abstract

Background: Bernard Soulier Syndrome (BSS) is a rare autosomal recessive disorder due to deficiency or dysfunction of the glycoprotein GPIb-V-IX complex on the platelet surface. It is also known as hemorrhagiparous thrombocytic dystrophy or congenital hemorrhagiparous thrombocytic dystrophy. The patient usually presents with severe and prolonged bleeding along with characteristics of giant blood platelets and low platelet counts. Manifestations of BSS include epistaxis, gum bleeding, purpuric rashes, menorrhagia, rarely melena, and hematemesis. On the other hand, immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder in which there is accelerated platelet destruction and reduced platelet production. Isolated thrombocytopenia without fever, lymphadenopathy, and organomegaly usually lead to the diagnosis of immune thrombocytopenia.

Case Presentation: A 20 years old female presented with complaints of recurrent episodes of epistaxis since childhood and menorrhagia during menarche. She was misdiagnosed as ITP elsewhere. Later, based on thorough clinical examination and investigation, the diagnosis was confirmed as BSS.

Conclusion: BSS should always be taken in the differential diagnosis of ITP, especially when persistent, refractory, and treated unsuccessfully with steroids or splenectomy.

« Previous
Graphical Abstract

[1]
Lanza, F. Bernard-Soulier syndrome (Hemorrhagiparous thrombocytic dystrophy). Orphanet J. Rare Dis., 2006, 1(1), 46.
[http://dx.doi.org/10.1186/1750-1172-1-46] [PMID: 17109744]
[2]
López, J.A.; Andrews, R.K.; Afshar-Kharghan, V.; Berndt, M.C. Bernard-Soulier syndrome. Blood, 1998, 91(12), 4397-4418.
[http://dx.doi.org/10.1182/blood.V91.12.4397] [PMID: 9616133]
[3]
Pham, A.; Wang, J. Bernard-Soulier syndrome: An inherited platelet disorder. Arch. Pathol. Lab. Med., 2007, 131(12), 1834-1836.
[http://dx.doi.org/10.5858/2007-131-1834-BSAIPD] [PMID: 18081445]
[4]
Kemahli, S.; Canatan, D.; Uysal, Z.; Akar, N.; Cin, S.; Arcasoy, A. DDAVP shortens bleeding time in Bernard-Soulier syndrome. Thromb. Haemost., 1994, 71(5), 675.
[http://dx.doi.org/10.1055/s-0038-1642502] [PMID: 8091397]
[5]
Ozelo, M.C.; Svirin, P.; Larina, L. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard–Soulier syndrome. Ann. Hematol., 2005, 84(12), 816-822.
[http://dx.doi.org/10.1007/s00277-005-1080-y] [PMID: 16044315]
[6]
Almeida, A.M.; Khair, K.; Hann, I.; Liesner, R. The use of recombinant factor VIIa in children with inherited platelet function disorders. Br. J. Haematol., 2003, 121(3), 477-481.
[http://dx.doi.org/10.1046/j.1365-2141.2003.04286.x] [PMID: 12716372]
[7]
Nagalla, S.; Sarode, R. Recent advances in understanding and management of acquired thrombocytopenia. F1000 Res., 2018, 7, 68.
[http://dx.doi.org/10.12688/f1000research.12309.1] [PMID: 29399327]
[8]
Konkle, B.A. Disorders of Platelets and Vessel Wall. In: Harrison’s principles of internal medicine, 20th ed; Jameson, J.L.; Kasper, D.L.; Longo, D.L.; Fauci, A.S.; Hauser, S.L.; Loscalzo, J., Eds.; McGraw Hill: New York, 2018, pp. 822-830.
[9]
Reisi, N. Bernard-Soulier syndrome or idiopathic thrombocytopenic purpura: A case series. Caspian J. Intern. Med., 2020, 11(1), 105-109.
[PMID: 32042394]
[10]
Dinkar, A.; Singh, J. Dengue infection in North India: An experience of a tertiary care center from 2012 to 2017. Tzu-Chi Med. J., 2019, 32(1), 36-40.
[PMID: 32110518]
[11]
Singh, J.; Dinkar, A.; Kumar, N.; Kumar, K. COVID-19 associated Pancytopenia (CAP): A clinical impact; Recent Adv. Inflamm. Allergy Drug Discov, 2022.
[http://dx.doi.org/10.2174/2772270817666221207094122]
[12]
Totonchi, A.; Eshraghi, Y.; Beck, D.; McCrae, K.; Guyuron, B. Von willebrand disease: Screening, diagnosis, and management. Aesthet. Surg. J., 2008, 28(2), 189-194.
[http://dx.doi.org/10.1016/j.asj.2007.12.002] [PMID: 19083526]
[13]
Raccuglia, G. Gray platelet syndrome. Am. J. Med., 1971, 51(6), 818-828.
[http://dx.doi.org/10.1016/0002-9343(71)90311-1] [PMID: 5129551]
[14]
HEGGLIN. R. Simultaneous constitutional changes in neutrophils and platelets. Helv. Med. Acta, 1945, 12, 439.
[15]
Milton, J.G.; Frojmovic, M.M.; Tang, S.S.; White, J.G. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS). Am. J. Pathol., 1984, 114(2), 336-345.
[PMID: 6696046]
[16]
Moiz, B.; Rashid, A. BSS misdiagnosed as ITP. Blood, 2013, 122(10), 1693.
[http://dx.doi.org/10.1182/blood-2013-04-495267] [PMID: 24137817]
[17]
Berndt, M.C.; Andrews, R.K. Bernard-Soulier syndrome. Haematologica, 2011, 96(3), 355-359.
[http://dx.doi.org/10.3324/haematol.2010.039883] [PMID: 21357716]
[18]
Jenkins, C.S.; Phillips, D.R.; Clemetson, K.J.; Meyer, D.; Larrieu, M.J.; Lüscher, E.F. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand’s disease. J. Clin. Invest., 1976, 57(1), 112-124.
[http://dx.doi.org/10.1172/JCI108251] [PMID: 1081991]
[19]
Almomani, M.H.; Mangla, A. Bernard Soulier Syndrome. StatPearls Publishing: Treasure Island (FL), 2022.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy